Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

Published by 23 Aug 2026

Drag the red line through time · ← → a day · Shift+← → a week. Later days aren’t drawn: they haven’t been published yet.

Scope · likely financings by canton

39 likely financings · 25 Jul 2026 – 23 Aug 2026 · the feed below shows one weekBS ✕ show all cantonsMap: Natural Earth

Likely financing: Looks like new money from outside investors: Claude, reading the entry and the rule signals, scores it 0.60 or higher.
Undecided: Some financing signals, not enough to call it: a score from 0.35 to below 0.60, or no usable score.
Capital increased: No sign of a financing round: the pre-filter found nothing to send to Claude, or Claude scored it below 0.35. Typical causes are converted loans, assets contributed in kind, reserves turned into capital or a conversion to an AG.
Confirmed round: A financing announcement on startupticker.ch names the company and matches this increase.

Published 17–23 Aug 2026 · canton BS

4 capital increases · 1 shown

Capital increases published 17–23 Aug 2026
Company	Status	Nominal share capital (CHF) before → after	New shares, % of post-step shares	Announced roundnot disclosed in the SHAB	SHAB published	Source
Vaderis Therapeutics AGBS · Die Gesellschaft bezweckt die Entwicklung und Vermarktung von neuen innovativen Medikamenten. Die …SHAB publication HR02-1006735763	Confirmed round · missed by classifierscore 0.35Announced round: USD 152’000’000 ↗	406’232.34 → 6’600’768.17New shares 93.8%	93.8%	USD 152’000’000 ↗	20 Aug 2026	SHAB publication HR02-1006735763

3 other capital increases published this week ▸